Child wasting and growth failure/ faltering are public health issues of concern, particularly in low- and middle-income countries. There is a glaring gap in reviews of cost and cost-effectiveness evidence to guide policy decisions on the settings within which to treat children with wasting, oedema and growth failure/faltering. This project aimed to address that gap and inform the World Health Organization’s (WHO) guidelines on where to treat.